The University of Bristol spinout is working on adapting cell therapies to solid tumours.

Adam Perriman, professor of bioengineering at University of Bristol, is every tech transfer professional’s dream faculty member. He gained his PhD from Australian National University in 2007 – not long before the global financial crisis threw the world’s economies into turmoil – and immediately began pondering the benefits of spinouts, which were still a rarity at the time.

“Things were looking rough in 2008,” he told Global University Venturing. “I was looking at the world and realised that the west…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?
Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).